Executive Medical Director, Penn Medicine Ann B. Barshingr Cancer Institute. Lancaster General Health
Joined November 2013
- Tweets 414
- Following 235
- Followers 695
- Likes 1,139
51 Photos and videos
May 31
Standing ovation for Daraxonrasib data! Amazing advancements for pancreatic cancer patients. #ASCO26.
6
234
Efrat Dotan MD retweeted
#ClinicalTrial EA6244, led by @YanaNajjarMD of @UPMCHillmanCC, is testing a less invasive treatment approach for older adults with early-stage #melanoma. Learn more: bit.ly/ea6244-study
1
1
135
Efrat Dotan MD retweeted
A new study reveals FOLFIRINOX is feasible for select elderly patients w/ pancreatic cancer. In an accompanying editorial, @ramsedhom & @efratdotan emphasized the study adds critical insights on the “tension between efficacy and tolerability.” @TargetedOnc spr.ly/6017hDOd9
2
4
224
Efrat Dotan MD retweeted
Feb 14
📌NALIRIFOX vs Gem-nabpaclitaxel in >70 y patients
subgroup analysis of NAPOLI 3 @ESMO_Open @myESMO
✅Benefit sustained
✅No signal for increased toxicity
👉esmoopen.com/article/S2059-7…
#cancer #omcology #MedX #pancreatic @OncoAlert @realbowtiedoc
23
61
3,534
Efrat Dotan MD retweeted
Jan 21
Imagine 4 new anticancer drugs Pallituzumab, Geriatriximab, Symptomab, & Exercizumab hit the market. They should dominate the plenary sessions at ASCO & command billion-dollar revenue. But they don't because they're nonpharmacologic & shame on us.
Read our opinion piece in @JCO_ASCO
ascopubs.org/doi/full/10.120…
5
36
105
23,090
Efrat Dotan MD retweeted
18 Dec 2025
@efratdotan & I in @JCOOP_ASCO on pancreatic cancer in older adults ascopubs.org/doi/10.1200/OP-…
1. PDAC needs a systems approach of evaluating fitness for older adults. We make the analogy that Edison's light bulb is useless without durable filaments, sockets, electric grids
2
8
18
1,214
Efrat Dotan MD retweeted
11 Dec 2025
Do you have advanced non-small cell #LungCancer and are age 70 or older? If so, you may be able to participate in this study of a new treatment approach. Learn more: bit.ly/ea5221-achieve cc: @BalazsHalmosMD, @efratdotan, @CPresGeriOncMD
2
3
375
Efrat Dotan MD retweeted
5 Dec 2025
Voting for ASCO Election closes Mon, Dec 8 @ 3PM ET! I am honored to be running as one of the candidates for the Nominating Committee. Visit asco.org/election to learn more and vote!
2
17
43
9,962
Efrat Dotan MD retweeted
28 Oct 2025
A new study shows that elevated early-onset cancer incidence is accompanied by similar increases in older adults. The increase is “not restricted to young adults but affects all generations," noted @LGHealth’s @efratdotan in an editorial. spr.ly/6019Ah0HL
1
2
229
Efrat Dotan MD retweeted
31 Oct 2025
PC3I & @PennCancer announce the creation a hub to address the needs of older adults w/ #cancer: The Center for Cancer & Aging.
Led by @efratdotan & @ramsedhom, the Center will focus on integrating patient-centered #geriatric principles into #cancercare.
pc3i.upenn.edu/news/penn-med…
1
2
9
395
Efrat Dotan MD retweeted
24 Oct 2025
Congrats @NVijayvergiaMD on being awarded the 2025 @NANETS1 Distinguished Clinician Award. You’re truly a leader in our field and such a big inspiration for so many like me. Thanks for your phenomenal and impactful work; this is such a well-deserved honor. @PamelaKunzMD @FoxChaseCancer
7
4
44
8,703
Efrat Dotan MD retweeted
23 Oct 2025
Do you have advanced non-small cell #LungCancer and are age 70 or older? If so, you may be able to participate in this study of a new treatment approach. Learn more: bit.ly/ea5221-achieve cc: @BalazsHalmosMD, @efratdotan, @CPresGeriOncMD
1
3
211
Efrat Dotan MD retweeted
23 Oct 2025
Excited to team up with @efratdotan in our new Center for Cancer & Aging @PennMedicine @PC3Innovation
We welcome collaboration from industry, start-ups, & academia to improve the care of older adults with cancer
pc3i.upenn.edu/our-work/pc3i…
1
1
19
3,481
Efrat Dotan MD retweeted
9 Jun 2025
Congratulations Neena and @FoxChaseCancer ! 👏🏽👏🏽👏🏽@NVijayvergiaMD
8 Jun 2025
Time to celebrate 🤩 @NVijayvergiaMD! She’s the new #GI Section Leader of @FoxChaseCancer 👏👏. I am sure she’s going do a FANTASTIC job!!!! I am SO proud of her!!!! CONGRATULATIONS 🎉🍾🎈🎊!!!! @ChrisCannMD #cancer #cancerresearch @eaonc
1
1
12
1,079
Efrat Dotan MD retweeted
1 Jun 2025
Such a well deserved standing ovation for Chris Booth and the Challenge trial. These data are quite powerful. Much stronger evidence than what we saw in plenaries today. #ASCO25
5
64
247
30,625
1 Jun 2025
New standard of care for stage III, improved DFS with the addition of atezolizumab to FOLfOX. Yet, many questions remain regarding the length of therapy and possible use of immunotherapy alone. #ASCO2025
4
19
857
31 May 2025
Inspiring presentation by @HKlepinMD on her journey in geriatric oncology. Congratulations for well deserved winner of the geriatric oncology ASCO award. #ASCO2025
1
2
12
435
Efrat Dotan MD retweeted
8 May 2025
Thrilled to share that our team @PennMedicine @PrincetonHealth has received the 2025 @ACCCBuzz Innovator Award for Geriatric Oncology Program! accc-cancer.org/home/about/a…
Older adults deserve care tailored to their needs—and we made it real! and scalable @PC3Innovation
6
5
35
2,134
Efrat Dotan MD retweeted
28 Feb 2025
Thank you @6abc for increasing awareness of the alarming rise of young adult cancers and for highlighting our program at @FoxChaseCancer designed to optimize the care of this underrepresented patient population 6abc.com/post/young-adult-ca…
4
13
1,969
Efrat Dotan MD retweeted
25 Jan 2025
Nivolumab/ipilimumab versus nivolumab in MSI mCRC (CheckMate 8HW): a randomised, open-label, phase 3 trial
👇Get the full paper in the @TheLancet
doi.org/10.1016/S0140-6736(2…
👉Convincing activity with acceptable toxicity
❗️Practice-changing
@myESMO
5
54
144
14,961